aipm
President of AIPM Ukraine
Anatoly Revin
Head of the Representative Office of Hungarian EGIS Pharmaceuticals PLC in Ukraine.
He has more than twenty years of experience in the pharmaceutical market of Ukraine in the positions of product manager of the Lundbek company (2002-2005), head of the external service division of the AstraZeneca company (2005-2009).
Since 2009 – General Director of the “Egis Pharmaceuticals PLS” Representative Office (until May 2015 – the “Egis Nyurt” Representative Office)
In 1995, he completed an internship at the Canadian Parliament as part of the Canadian-Ukrainian parliamentary program.
Since 2009, he has been participating in the work of the Health Care Committee of the European Business Association (EBA).
Since 2011, he has been actively participating in the work of the Association of Representatives of International Pharmaceutical Manufacturers (AIPM Ukraine).
In 2017, he was elected President of the Association of Representatives of International Pharmaceutical Manufacturers (AIPM Ukraine).
Vice-President of AIPM Ukraine
Stanislav Kornev
Head of the Representative Office of the Belgian company “UCB Pharma GmbH” in Ukraine.
He has more than twenty years of experience in the pharmaceutical market of Ukraine in the positions of head of the external service of Roche Consumer Health (2001-2005), head of the onco-biotechnological department of Schering Plough (2005-2008), head of the pharmaceutical department of Alcon Pharmaceuticals (2008-2014).
Since 2014, he has been the Head of the Representative Office of the company “UCB Pharma GmbH” in Ukraine.
Since 2014, he has been participating in the work of the Health Care Committee of the European Business Association (EBA).
In 2017, he was elected Vice President of the Association of Representatives of International Pharmaceutical Manufacturers (AIPM Ukraine).
The Executive Director of AIPM Ukraine
Volodymyr Ignatov
He has more than thirty years of experience in the pharmaceutical market of Ukraine as the head of the representative office of Ron-Poulenc Rohrer (1993-1999), Aventis (2000-2005), AstraZeneca (2005-2009) and IPSEN Pharma (2012-2020).
From 2001 to 2009, he actively worked in the European Business Association (EBA).
From 2004 to 2005 – Vice-President of EBA.
From 2003 to 2009, he headed the group of European pharmaceutical manufacturers of the EBA Health Committee.
Since 2010, he has been working as the Executive Director of the Association of Representatives of International Pharmaceutical Manufacturers (AIPM Ukraine).